Skip to content

Revvity Inc. Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 3, 2026 results vs estimates

Revvity Inc. · E.RVTY.NYSE · United States
Use symbol E.RVTY.NYSE in our API & Excel add-in to retrieve this data ↓
165.78
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 25.88%

Revvity Inc. Forecast

Revvity Inc. short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 25.9% a year, a typical one-standard-deviation range is 159.74–171.82 over a week, 153.40–178.16 over a month and 122.88–208.68 over a year. (Signals as of 1 Nov 2026.)

Revvity Inc. Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Revvity Inc.
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Revvity Inc.
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Revvity Inc.
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Revvity Inc.
P/E
73.22x
Stretched vs own history
QoQ +24.8%
YoY +51.3%
now 73.216639.17 low74.69 high
ⓘP/E As of 22 Nov 2026.See Revvity Inc. returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Revvity Inc.
P/S
6.30x
Stretched vs own history
QoQ +31.6%
YoY +53.2%
now 6.30183.33 low6.3 high
ⓘP/S As of 22 Nov 2026.See Revvity Inc. returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Revvity Inc.
P/B
2.55x
Stretched vs own history
QoQ +32.2%
YoY +62.5%
now 2.54961.31 low2.55 high
ⓘP/B As of 22 Nov 2026.See Revvity Inc. returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Revvity Inc.
EV/EBITDA
26.29x
Stretched vs own history
QoQ +24.0%
YoY +44.5%
now 26.286315.79 low26.29 high
ⓘEV/EBITDA As of 22 Nov 2026.See Revvity Inc. returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Revvity Inc.
EV/Sales
7.04x
Stretched vs own history
QoQ +26.1%
YoY +41.4%
now 7.04034.23 low7.04 high
ⓘEV/Sales As of 22 Nov 2026.See Revvity Inc. returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Revvity Inc.
FCF Yield
3.2%
Mid-range vs own history
QoQ −20.5%
YoY −25.8%
now 3.19223.15 low5.38 high
ⓘFCF Yield As of 22 Nov 2026.See Revvity Inc. returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Revvity Inc.
Earnings Yield
1.4%
Weak vs own history
QoQ −19.9%
YoY −33.9%
now 1.36581.34 low2.55 high
ⓘEarnings Yield As of 22 Nov 2026.See Revvity Inc. returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Revvity Inc.
Dividend Yield
0.2%
Weak vs own history
QoQ −25.6%
YoY −41.3%
now 0.16950.17 low0.35 high
ⓘDividend Yield As of 22 Nov 2026.See Revvity Inc. returns when Dividend Yield looked like now →Opens Return analysis with the filter Dividend Yield within ±5% of today
Revvity Inc.
Market Cap
$18.5B
Highest in 5 years
QoQ +33.0%
YoY +60.2%
now 18538.51439,499 low18,539 high
ⓘMarket Cap As of 22 Nov 2026.See Revvity Inc. returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Revvity Inc.
Net Debt
$2.2B
Mid-range vs own history
QoQ −6.3%
YoY −10.9%
now 2172.2332,172 low2,596 high
ⓘNet Debt As of 22 Nov 2026.See Revvity Inc. returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Revvity Inc.
Net Debt / EBITDA
2.76x
Mid-range vs own history
QoQ −8.8%
YoY −12.9%
now 2.7572.76 low3.39 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Revvity Inc. returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Revvity Inc.
Current Ratio
2.65x
Mid-range vs own history
QoQ +47.4%
YoY +51.3%
now 2.65351.68 low2.65 high
ⓘCurrent Ratio As of 22 Nov 2026.See Revvity Inc. returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Revvity Inc.
Quick Ratio
2.10x
Mid-range vs own history
QoQ +39.6%
YoY +45.5%
now 2.09921.4 low2.1 high
ⓘQuick Ratio As of 22 Nov 2026.See Revvity Inc. returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Revvity Inc.
Interest Coverage
4.07x
Mid-range vs own history
QoQ +7.9%
YoY +2.7%
now 4.07243.77 low4.07 high
ⓘInterest Coverage As of 22 Nov 2026.See Revvity Inc. returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Revvity Inc.
Debt / Equity
0.38x
Low vs own history
QoQ −17.7%
YoY −16.7%
now 0.38030.38 low0.48 high
ⓘDebt / Equity As of 22 Nov 2026.See Revvity Inc. returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Revvity Inc.
Piotroski F-Score
8
Strong vs own history
QoQ +60.0%
YoY +33.3%
now 85 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Revvity Inc. returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Revvity Inc.
Altman Z-Score
3.87
Strong vs own history
QoQ +34.1%
YoY +51.0%
now 3.87482.28 low3.87 high
ⓘAltman Z-Score As of 22 Nov 2026.See Revvity Inc. returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Revvity Inc., red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Revvity Inc. fundamentals: income statement, balance sheet & cash flow

Revvity Inc. reported revenue of $2.86bn and net income of $241.7m in FY2025, the year ended 31 December 2025 — revenue up 3.7% and net income down 18.3% on the prior year. Free cash flow was $508.3m. These figures are as reported in the filings, not restated: 41 fiscal years and 165 quarters of history, back to December 1985. 81 FINRA short-interest settlements are published alongside them, back to May 2023.

Revenue (FY2025)
$2.86bn
+3.7%
Net income
$241.7m
-18.3%
Gross margin
53.08%
Free cash flow
$508.3m
-6.2%
Net debt
$2.60bn
Shares short (30 Oct 2026)
6.53m
3.90 days to cover
Revvity Inc. income statement, annual, as reported · USD millions unless stated
USD millionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue2,856.12,755.02,750.63,311.83,827.8
Cost of revenue1,340.01,432.41,428.41,551.11,545.9
Gross profit1,516.11,322.71,322.21,760.72,282.0
Research & development215.8196.8216.6221.6200.3
Operating income356.6410.5399.5781.11,340.0
EBITDA765.8840.3713.61,182.81,617.2
Interest expense92.296.398.8104.0102.1
Pre-tax income268.3316.1183.0651.81,203.6
Income tax25.833.13.5139.2314.1
Net income241.7295.8-118.4569.2943.2

Download Revvity Inc. fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.RVTY.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 41 fiscal years and 165 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Revvity Inc.

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Revvity Inc. Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Revvity Inc.; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Revvity Inc.’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Revvity Inc. behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Revvity Inc. (United States)

Revvity Inc. is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Revvity Inc.?
Revvity Inc. is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Revvity Inc. price?
The latest close is 165.78 (1 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Revvity Inc. in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Revvity Inc.?
20-day realised volatility is 25.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 7.5% over a month and 3.6% over a week.
What factors affect Revvity Inc.?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Revvity Inc., grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Revvity Inc.?
58 backtested tactical asset allocation strategies trade Revvity Inc. through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Revvity Inc. returns analysed?
The Statistical Distribution of Returns section shows the distribution of Revvity Inc. daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Revvity Inc. historical data?
In the Free historical data section of this page: the last 10 years of Revvity Inc. daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Revvity Inc. historical data (last 10 years)

Browse or instantly download the last 10 years of Revvity Inc. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RVTY.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-20145.22
2026-11-19151.59
2026-11-18152.43
2026-11-17147.79
2026-11-16148.85
2026-11-13154.39
2026-11-12157.02
2026-11-11158.25
2026-11-10159.1
2026-11-09160.72
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptors and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.